Literature DB >> 2258922

Temperature-dependent switching between "wild-type" and "mutant" forms of p53-Val135.

J Milner1, E A Medcalf.   

Abstract

The p53 gene is a suppressor of abnormal cell growth but is also subject to oncogenic activation by mutation. The mutant allele p53-Val135, has recently been discovered to be temperature-sensitive and functions as an oncogene at 37 degrees C and as a tumor suppressor at 32.5 degrees C. In order to investigate the molecular mechanism underlying the temperature sensitivity of p53-Val135 rabbit reticulocyte lysate was used to translate the p53 mRNAs in vitro at 37 degrees C and at 30 degrees C. The immunoreactivity and T antigen binding of wild-type protein p53-Ala135 were unaffected by temperature and were similar to wild-type p53 expressed in vivo. In contrast, the mutant p53-Val135 protein was markedly affected by temperature. At 37 degrees C p53-Val135 showed reduced T antigen binding and did not react with monoclonal antibodies PAb246 and PAb1620. At 30 degrees C, p53-Val135 behaved as the wild-type p53. Temperature also exerted a post-translational effect on p53-Val135 with complete conversion from wild-type to mutant phenotype within two minutes of temperature shift from 30 degrees C to 37 degrees C. There was incomplete conversion from mutant to wild-type phenotype when the temperature was shifted down from 37 degrees C to 30 degrees C. We propose that the temperature dependent forms of p53-Val135 represent conformational variants of the p53 protein with opposing functions in cell growth control.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258922     DOI: 10.1016/0022-2836(90)90371-R

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

1.  Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature.

Authors:  James S Butler; Stewart N Loh
Journal:  Protein Sci       Date:  2006-09-25       Impact factor: 6.725

2.  Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding.

Authors:  D Michael-Michalovitz; F Yehiely; E Gottlieb; M Oren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Mammalian p53 can function as a transcription factor in yeast.

Authors:  E Schärer; R Iggo
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

4.  p53 DNA binding can be modulated by factors that alter the conformational equilibrium.

Authors:  K G McLure; P W Lee
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

5.  Proteolysis by calpains: a possible contribution to degradation of p53.

Authors:  M Pariat; S Carillo; M Molinari; C Salvat; L Debüssche; L Bracco; J Milner; M Piechaczyk
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

6.  Increased salt concentration reversibly destabilizes p53 quaternary structure and sequence-specific DNA binding.

Authors:  S Butcher; P Hainaut; J Milner
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

7.  Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway.

Authors:  D R Chowdary; J J Dermody; K K Jha; H L Ozer
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

8.  Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo.

Authors:  Harumi Shimizu; David Saliba; Maura Wallace; Lee Finlan; Patrick R R Langridge-Smith; Ted R Hupp
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

Review 9.  Strategies for manipulating the p53 pathway in the treatment of human cancer.

Authors:  T R Hupp; D P Lane; K L Ball
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

10.  p53Val135 temperature sensitive mutant suppresses growth of human breast cancer cells.

Authors:  D Eliyahu; S Evans; N Rosen; S Eliyahu; J Zwiebel; S Paik; M Lippman
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.